70-80 million COVID vaccine doses being made per month, plans underway to see requirement for India: SII CEO

Jan 12, 2021

Pune (Maharashtra) [India], January 12 : The Serum Institute of India (SII) makes 70 to 80 million doses every month and planning is underway...

Covid situation in India better than elsewhere: SII CEO Adar Poonawalla

Jan 09, 2023

Serum Institute of India CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed...

SII CEO says safe, effective COVID-19 vaccine ready for roll-out

Jan 03, 2021

New Delhi [India], January 3 : Covishield, India's first COVID-19 vaccine is approved, safe, effective and ready for roll-out in the coming weeks, said...

COVID-19 vaccine Covovax now available for children in India: Adar Poonawalla

May 03, 2022

New Delhi [India], May 3 : Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the COVID-19 vaccine Covovax is now...

Adar Poonawalla receives Covishield shot, wishes PM Modi success in launching vaccination rollout

Jan 16, 2021

New Delhi [India], January 16 : Serum Institute of India (SII) CEO Adar Poonawalla on Saturday wished Prime Minister Narendra Modi success in launching...

"Will put in a strong, competitive bid": SII CEO Adar Poonawalla announces plan to bid for RCB

Jan 22, 2026

Serum Institute of India (SII) CEO Adar Poonawala on Thursday announced the decision to bid for the defending Champions of the Indian Premier League...